Boston, MA 05/27/2014 (wallstreetpr) – The medical equipment manufacturer ResMed Inc. (NYSE:RMD) announced the introduction of new ventilators that it says are portable and user-friendly. The move mirrors the company’s commitment to bring to the market quality products that will distinguish it from the competition and attract higher revenue and profit.
The products, Astral 100 and Astral 150, have already been launched in the European and Asia-Pacific markets. However, ResMed hopes to introduce the products to the U.S. market later this year. It is currently waiting for the approval of the U.S. Food and Drug Administration.
Enhance features
The life support ventilators offer greater mobility and easy usage and provide a solution for the patients of the neuromuscular disease COPD, and other breathing disorders in adults and children. The devices also feature a large touchscreen display and easily navigable display.
Expanding into emerging markets
Given the user-friendly and portability of the ventilators, ResMed Inc. (NYSE:RMD) expects to use the products to expand its reach in emerging markets. An expanded international operation coupled with a healthy domestic market should support higher revenue.
But even as the company seeks a bigger reach in the international markets, more so the emerging markets of Asia-Pacific, ResMed Inc. (NYSE:RMD) hopes to achieve efficiency in its operations and supply chain with the aim to support big bottom-line growth.
In the most recent quarter, ResMed reported encouraging results, although analysts expected bigger figures for the quarter. It posted 3Q2014 earnings per share of 63 cents, against the consensus estimate of 64 cents. Revenue for the quarter was $397.80 million, against the consensus estimate of $401 million. Both revenue and earnings increased by significant margins on a year-over-year basis.
The management is optimistic of a positive performance in the current quarter and fiscal 2014.
Curbing expenses and costs are the key areas that ResMed Inc. (NYSE:RMD) is looking into to support bottom-line growth. The company also promised to look into new cost-saving opportunities within its system.
Shares of ResMed Inc. (NYSE:RMD) are up 6.29 percent since the beginning of 2014.
